Emcure Pharmaceuticals Ltd., a leading Indian pharma company with a strong focus on women’s health, announces its entry into the daily supplements space with the expansion of its Arth range. With a ...

Motilal Oswal, has come out with its report on Emcure Pharmaceuticalss Ltd. The research firm has recommended to “ Subscribe- Long Term” the ipo in its research report as on July 02 2024.

New DelhiEmcure Pharmaceuticals on Wednesday said the US health regulator has issued two observations after inspecting its Pune-based active pharmaceutical ingredients (API) manufacturing facility.

Emcure Pharmaceuticals has opened its new formulation research and development (R&D) centre in Ahmedabad, in the Indian state of Gujarat. The centre will focus on developing complex drug delivery ...

Emcure Pharmaceuticals Ltd shares surged 9.91 per cent in Tuesday's trade to hit a day high of Rs 1,440.90. The stock was last seen trading 6.19 per cent up at Rs 1,392.15. At this price, it has ...

Pune-based Emcure Pharmaceuticals has come forth again to publicly list its shares on exchanges. In 2014, the company had attempted to hit the stock exchanges, but reportedly did not pursue it ...